Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

156

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	20mg/0.5ml	Injectable concentrated solution+diluent	4,567,721 L.L
L01CD02	TAXOTERE	B	Docetaxel (trihydrated) - 80mg/4ml	80mg/4ml	Injectable concentrated solution+diluent	24,150,868 L.L
L01CD02	TAXOTERE	B	Docetaxel (trihydrated) - 80mg/4ml	80mg/4ml	Injectable concentrated solution+diluent	24,150,868 L.L
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	80mg/2ml	Injectable concentrated solution+diluent	16,777,239 L.L
L01CD02	DOCETAXEL HOSPIRA	G	Docetaxel - 20mg/2ml	20mg/2ml	Injectable concentrated solution	4,812,300 L.L
L01CD02	DOCETAXEL HOSPIRA	G	Docetaxel - 160mg/16ml	160mg/16ml	Injectable concentrated solution	703,374 L.L
L01CE02	IRINOTECAN GP PHARM	G	Irinotecan HCl trihydrate - 100mg/5ml	100mg/5ml	Injectable concentrated solution	5,239,642 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,362,219 L.L
L01CE02	CAMPTO CONCENTRATE FOR INFUSION	B	Irinotecan HCl trihydrate - 40mg/2ml	40mg/2ml	Injectable concentrated solution	3,033,053 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 10mg/5ml	10mg/5ml	Injectable concentrated solution	428,686 L.L
L01DB01	CAELYX	B	Doxorubicin HCl pegylated liposomes - 20mg/10ml	20mg/10ml	Injectable concentrated solution	32,513,227 L.L
L01DB01	CAELYX	B	Doxorubicin HCl pegylated liposomes - 20mg/10ml	20mg/10ml	Injectable concentrated solution	32,513,227 L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 2mg/ml	50mg/25ml	Injectable concentrated solution	1,804,780 L.L
L01DB01	CAELYX	B	Doxorubicin HCl pegylated liposomes - 20mg/10ml	20mg/10ml	Injectable concentrated solution	5,319,413 L.L
L01DB01	CAELYX	B	Doxorubicin HCl pegylated liposomes - 20mg/10ml	20mg/10ml	Injectable concentrated solution	5,319,413 L.L
L01DB03	EPIRUBICINE EBEWE	G	Epirubicin HCl - 2mg/ml	50mg/25ml	Injectable concentrated solution	3,271,971 L.L
C01EA01	PROSTIN VR	B	Alprostadil - 500mcg/ml	500mcg/ml	Injectable concentrated solution	8,302,374 L.L
L01DB07	MITOXANTRON EBEWE	G	Mitoxantrone - 20mg/10ml	20mg/10ml	Injectable concentrated solution	11,064,120 L.L
J01GB06	LIKACIN	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable concentrated solution	349,399 L.L
M05BA08	ZOMETA	B	Zoledronic acid (monohydrate) - 4mg/5ml	4mg/5ml	Injectable concentrated solution	13,697,658 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	2,302,853 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	3,886,065 L.L
B03AC	VENOFER I.V.	B	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	3,594,914 L.L
B03AC	IVIRON	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	1,745,203 L.L
B05XA	PEDITRACE	B	Sodium selenite 5H2O (anhydrous) - 6.66mcg/ml, Sodium fluoride - 126mcg/ml, Potassium iodide - 1.31mcg/ml, Zinc chloride - 521mcg/ml, Copper chloride - 53.7mcg/ml, Manganese chloride 4H2O - 3.6mcg/ml		Injectable concentrated solution	4,749,635 L.L
B05XA01	CHLORURE DE POTASSIUM PROAMP	G	Potassium chloride - 0.0746g/ml	0.0746g/ml	Injectable concentrated solution	1,252,461 L.L
L01FE02	VECTIBIX	BioTech	Panitumumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	147,763,999 L.L
L01FE02	VECTIBIX	BioTech	Panitumumab - 100mg/5ml	100mg/5ml	Injectable concentrated solution	40,364,800 L.L
L04AA23	TYSABRI	BioTech	Natalizumab - 300mg/15ml	300mg/15ml	Injectable concentrated solution	126,830,594 L.L

...

156

...